— Know what they know.
Not Investment Advice

NOVN NASDAQ

Novan, Inc.
1W: +11.3% 1M: -88.1% 3M: -95.1% 1Y: -98.0% 3Y: -99.1% 5Y: -99.8%
$0.09
Last traded 2023-08-21 — delisted
NASDAQ · Healthcare · Biotechnology · $2.6M mcap · 26M float · 4.64% daily turnover

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$24M +736.6% ▲
5Y CAGR: +61.6%
Gross Profit
$16M +475.1% ▲
5Y CAGR: +50.0%
Operating Income
-$35M -18.3% ▼
Net Income
-$20M +32.2% ▲
EPS (Diluted)
$-0.89 +47.3% ▲
EBITDA
-$28M -11.4% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$6M$4M$4M$3M$24M
YoY Growth+180.0%-25.3%-6.0%-32.9%+736.6%
Cost of Revenue$23M$25M$0$0$7M
Gross Profit-$17M-$21M$4M$3M$16M
Gross Margin-284.7%-462.3%100.0%100.0%68.7%
R&D Expenses$23M$25M$20M$20M$16M
SG&A Expenses$12M$10M$11M$12M$34M
Operating Expenses$35M$35M$30M$33M$52M
Operating Income-$29M-$31M-$30M-$30M-$35M
Operating Margin-476.7%-685.5%-718.0%-1060.1%-149.9%
Interest Expense$1M$2K$0$0$1M
Income Before Tax-$13M-$31M-$29M-$30M-$31M
Tax Expense-$16M$138K$870K-$855K-$12M
Net Income-$13M-$31M-$30M-$29M-$20M
Net Margin-211.5%-687.5%-716.8%-1021.9%-82.9%
EPS (Diluted)$-4.91$-11.72$-3.05$-1.69$-0.89
EBITDA-$27M-$28M-$24M-$30M-$28M
Shares Outstanding3M3M10M17M22M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms